Therapeutic Evaluation Of Early Intervention For High-risk Cerebral Palsy

Background and purposeHigh-risk infants refers to the infant with risky factors which endanger their growth infoetal,childbirth,and the growth period. With the rapid development of the perinatal medicine, the survivalprobability have been increased evidently in high-risk infants, which makes the incidence of cerebralpalsy(CP) increasing sharping. The study is tried to analyze the therapeutic effect of early interventiontreatment on high-risk cerebral palsy.MethodsTotally67infants with high-risk cerebral palsy were divided into the super early interventiongroup (1-3months old, n=36cases) and the early intervention group (4-6months old, n=31cases),accordingto the age for treatment. Each group was treated with the exercise therapy, that is Bobath rehabilitation andVojta rehabilitation; finally, momosialotetrahexosylganglioside sodium infusion was carried out with5%glucose. The treatment period would last for3months. Then, the treatment evaluation was involved inGesell assessment law, muscle tension inspection, Vojta posture reflection, and image alterations of brainCT before and after treatment,The Gesell developmental scales were used to test the developmentquotient(DQ) and development age(DA) of two groups after3months treatment.ResultsAfter3months training, the scores of DA is lower than CA of two groups, the super earlyintervention group has higher scores than the early intervention group. The scores of DQ, muscle tension,Vojta posture reflection and CT images were improved well in two treatment groups. The infants，symptoms were improved well after treatment in either super early intervention group or early interventiongroup with significant difference (P﹤0.05). Comparing between the two groups, the efficacy of super earlyintervention group was much better than early intervention group after treatment, suggesting early therapyis necessary for the disease.ConclusionsEarly intervention treatment on high-risk cerebral palsy has significant effects on symptoms, and early therapy is necessary for the high-risk infants.